Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-244X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] ; volume:5 ; number:1 ; day:24 ; month:1 ; year:2005 ; pages:1-8 ; date:12.2005
BMC psychiatry ; 5, Heft 1 (24.1.2005), 1-8, 12.2005

Creator: Carey, Paul D.

Contributor: Vythilingum, Bavanisha
Seedat, Soraya
Muller, Jacqueline E.
van Ameringen, Michael
Stein, Dan J.
SpringerLink (Online service)

DOI: 10.1186/1471-244X-5-5

URN: urn:nbn:de:1111-2016030423542

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Carey, Paul D.
Vythilingum, Bavanisha
Seedat, Soraya
Muller, Jacqueline E.
van Ameringen, Michael
Stein, Dan J.
SpringerLink (Online service)

Other Objects (12)

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

$Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]$

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Hochschulschrift

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

$Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]$

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Hochschulschrift

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

$Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]$

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Hochschulschrift

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia

Obsessive-compulsive disorder in adults

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders

Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure

Correction to: Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Overactive performance monitoring in obsessive-compulsive disorder

Embitterment and metacognition in obsessive–compulsive disorder

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Related objects

Reset password